GlassScriptPhysician profile
Brittney Judith Aupperle
NPI 1477283109
$7,409.80
in general payments reported to CMS, 2019-2025
26 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $938 · 2023: $2,105 · 2024: $3,215 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,047 · Travel and Lodging: $2,325 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,047.18 |
| Travel and Lodging | $2,324.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,050.10 | 2023-2024 | Axonics, Bulkamid |
| Teleflex LLC | $1,130.75 | 2022-2024 | Urolift |
| Astellas Pharma US INC | $797.64 | 2022-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $574.65 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $355.83 | 2022-2025 | Keytruda, Lynparza |
| Tolmar, INC. | $312.04 | 2023-2025 | Jatenzo, Eligard |
| Boston Scientific Corporation | $286.78 | 2023-2025 | Axonics, Bulkamid, Ams 700 |
| Janssen Biotech, INC. | $269.41 | 2024-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $259.28 | 2022-2025 | |
| Abbvie INC. | $246.65 | 2022-2025 | |
| Urovant Sciences INC | $198.87 | 2022 | |
| Olympus America INC. | $143.33 | 2023-2025 | Itind System, Olympus, Hd Camera Head |
| Myriad Genetic Laboratories, INC. | $141.06 | 2024-2025 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $138.25 | 2022-2024 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $91.52 | 2023 | Givlaari |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $69.65 | 2024-2025 | |
| Medtronic, INC. | $54.83 | 2024 | Interstim |
| Accord Healthcare, INC. | $53.76 | 2022-2024 | |
| Coloplast Corp | $50.43 | 2022-2024 | Speedicath |
| Urogen Pharma, INC. | $46.10 | 2023-2024 | |
| Dentsply Ih Ab | $38.97 | 2025 | Lofric |
| 180 Medical, INC. | $27.62 | 2024 | |
| Procept Biorobotics Corporation | $24.52 | 2025 | |
| Laborie Medical Technologies Corp. | $19.86 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $15.04 | 2022 | |
| Phathom Pharmaceuticals, INC. | $12.86 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Aupperle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.